EGFR can trigger the PI3K signaling pathway as well as the MAPK signaling pathway, which can result in the promotion of the proliferation, differentiation, and angiogenesis of CRC cells and inhibition of apoptosis. This evidence concerns the gene EGFR and colorectal carcinoma.